Literature DB >> 27241017

Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant.

Emily F Mason1, Ronald D Brown1, David P Szeto1, Christopher J Gibson2, Yonghui Jia1, Elizabeth P Garcia1, Caron A Jacobson2, Paola Dal Cin1, Frank C Kuo1, Geraldine S Pinkus1, Neal I Lindeman1, Lynette M Sholl1, Jon C Aster1, Elizabeth A Morgan1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27241017     DOI: 10.1080/10428194.2016.1185786

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  18 in total

Review 1.  Hairy cell leukemia: present and future directions.

Authors:  Robert J Kreitman
Journal:  Leuk Lymphoma       Date:  2019-05-09

2.  CBL-MZ is not a single biological entity: evidence from genomic analysis and prolonged clinical follow-up.

Authors:  Helen Parker; Neil Robert McIver-Brown; Zadie A Davis; Marina Parry; Matthew J J Rose-Zerilli; Aliki Xochelli; Jane Gibson; Renata Walewska; Jonathan C Strefford; David G Oscier
Journal:  Blood Adv       Date:  2018-05-22

3.  Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations.

Authors:  Benjamin H Durham; Bartlomiej Getta; Sascha Dietrich; Justin Taylor; Helen Won; James M Bogenberger; Sasinya Scott; Eunhee Kim; Young Rock Chung; Stephen S Chung; Jennifer Hüllein; Tatjana Walther; Lu Wang; Sydney X Lu; Christopher C Oakes; Raoul Tibes; Torsten Haferlach; Barry S Taylor; Martin S Tallman; Michael F Berger; Jae H Park; Thorsten Zenz; Omar Abdel-Wahab
Journal:  Blood       Date:  2017-08-11       Impact factor: 22.113

4.  Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation.

Authors:  Janine Schmidt; Joan Enric Ramis-Zaldivar; Ferran Nadeu; Blanca Gonzalez-Farre; Alba Navarro; Caoimhe Egan; Ivonne Aidee Montes-Mojarro; Teresa Marafioti; Jose Cabeçadas; Jon van der Walt; Stefan Dojcinov; Andreas Rosenwald; German Ott; Irina Bonzheim; Falko Fend; Elias Campo; Elaine S Jaffe; Itziar Salaverria; Leticia Quintanilla-Martinez
Journal:  Blood       Date:  2017-05-22       Impact factor: 22.113

5.  Institutional implementation of clinical tumor profiling on an unselected cancer population.

Authors:  Lynette M Sholl; Khanh Do; Priyanka Shivdasani; Ethan Cerami; Adrian M Dubuc; Frank C Kuo; Elizabeth P Garcia; Yonghui Jia; Phani Davineni; Ryan P Abo; Trevor J Pugh; Paul van Hummelen; Aaron R Thorner; Matthew Ducar; Alice H Berger; Mizuki Nishino; Katherine A Janeway; Alanna Church; Marian Harris; Lauren L Ritterhouse; Joshua D Campbell; Vanesa Rojas-Rudilla; Azra H Ligon; Shakti Ramkissoon; James M Cleary; Ursula Matulonis; Geoffrey R Oxnard; Richard Chao; Vanessa Tassell; James Christensen; William C Hahn; Philip W Kantoff; David J Kwiatkowski; Bruce E Johnson; Matthew Meyerson; Levi A Garraway; Geoffrey I Shapiro; Barrett J Rollins; Neal I Lindeman; Laura E MacConaill
Journal:  JCI Insight       Date:  2016-11-17

Review 6.  The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practice.

Authors:  Frank C Kuo; Brenton G Mar; R Coleman Lindsley; Neal I Lindeman
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

7.  BRAF in the cross-hairs.

Authors:  Mark B Geyer; Omar Abdel-Wahab; Martin S Tallman
Journal:  Expert Rev Hematol       Date:  2019-02-26       Impact factor: 2.929

8.  Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.

Authors:  Yi Wang; Tingyu Wang; Ying Yu; Qi Wang; Yuting Yan; Ru Li; Qi Sun; Wenjie Xiong; Rui Lyu; Zhen Yu; Wei Liu; Weiwei Sui; Wenyang Huang; Huijun Wang; Chengwen Li; Jun Wang; Dehui Zou; Gang An; Jianxiang Wang; Lugui Qiu; Shuhua Yi
Journal:  Ann Hematol       Date:  2022-04-18       Impact factor: 3.673

Review 9.  Advances in the Treatment of Hairy Cell Leukemia Variant.

Authors:  Julie Tran; Charles Gaulin; Martin S Tallman
Journal:  Curr Treat Options Oncol       Date:  2022-02-18

Review 10.  Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.

Authors:  Jérôme Paillassa; Elsa Maitre; Xavier Troussard
Journal:  Curr Oncol Rep       Date:  2022-04-11       Impact factor: 5.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.